US$ 25.79
health partners glp 1 coverage Perspectives from employers on the costs and issues associated with covering GLP-1 agonists for weight loss Technologies enabling long-term health outcomes
Description
Common side effects include nausea, vomiting, diarrhea, headaches, and acid reflux

Dehydration can concentrate thyroid hormone in the blood, artificially altering lab values, and can worsen the thirst that tirzepatide sometimes causes

The American Society of Anesthesiologists also warns that delayed stomach emptying increases the risk of vomiting and aspiration happening during surgery
During this period, effects gradually diminish

Abstract Abstract The increasing global prevalence of type 2 diabetes and obesity has led to rising use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs)